These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 20876672)
1. Value of the new bone classification system for pediatric patients with chronic kidney disease. Jorgetti V; Drüeke TB Clin J Am Soc Nephrol; 2010 Oct; 5(10):1730-1. PubMed ID: 20876672 [No Abstract] [Full Text] [Related]
2. Value of the new bone classification system in pediatric renal osteodystrophy. Bakkaloglu SA; Wesseling-Perry K; Pereira RC; Gales B; Wang HJ; Elashoff RM; Salusky IB Clin J Am Soc Nephrol; 2010 Oct; 5(10):1860-6. PubMed ID: 20634327 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry. Ferreira A; Saraiva M; Behets G; Macedo A; Galvão M; D'Haese P; Drüeke TB J Nephrol; 2009; 22(6):783-93. PubMed ID: 19967658 [TBL] [Abstract][Full Text] [Related]
5. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5. Lehmann G; Ott U; Kaemmerer D; Schuetze J; Wolf G Clin Nephrol; 2008 Oct; 70(4):296-305. PubMed ID: 18826854 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure]. Ziółkowska H; Roszkowska-Blaim M Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516 [TBL] [Abstract][Full Text] [Related]
7. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure]. Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939 [TBL] [Abstract][Full Text] [Related]
8. Biological markers in the diagnosis of the different forms of renal osteodystrophy. Ferreira A; Drüeke TB Am J Med Sci; 2000 Aug; 320(2):85-9. PubMed ID: 10981481 [TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children. Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371 [TBL] [Abstract][Full Text] [Related]
10. [Value of bloodless methods in the study of renal osteodystrophy: comparison with bone histomorphometry]. González-Posada JM; Torres A; Lorenzo V; Losada M; Maceira B; Hernández Nieto L; Díaz-Flores L Med Clin (Barc); 1987 Feb; 88(7):268-73. PubMed ID: 3561071 [No Abstract] [Full Text] [Related]
11. Trends and consequences of mineral bone disorder in haemodialysis patients: lessons from The Dialysis Outcomes and Practice Patterns Study (DOPPS). Blayney MJ; Tentori F J Ren Care; 2009 Mar; 35 Suppl 1():7-13. PubMed ID: 19222725 [TBL] [Abstract][Full Text] [Related]
12. A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. Meany DL; Jan de Beur SM; Bill MJ; Sokoll LJ Clin Chem; 2009 Sep; 55(9):1737-9. PubMed ID: 19717659 [No Abstract] [Full Text] [Related]
13. Correlations between bone histopathology and serum biochemistry in uremic patients on chronic hemodialysis. Canavese C; Barolo S; Gurioli L; Cadario A; Portigliatti M; Isaia G; Thea A; Marangella M; Bongiorno P; Cavagnino A; Peona C; Boero R; D'Amicone M; Cardelli R; Rossi P; Piccoli G Int J Artif Organs; 1998 Aug; 21(8):443-50. PubMed ID: 9803345 [TBL] [Abstract][Full Text] [Related]
14. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay. Cantor T; Sci B Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858 [TBL] [Abstract][Full Text] [Related]
15. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of renal osteopathy]. Schulz W Dtsch Med Wochenschr; 1978 Dec; 103(51):2023-5. PubMed ID: 729472 [No Abstract] [Full Text] [Related]
17. [Renal osteodystrophy]. Schober HC Z Urol Nephrol; 1986 Oct; 79(10):595-602. PubMed ID: 3811647 [No Abstract] [Full Text] [Related]
18. Does PTH offer additive value to ALP measurement in assessing CKD-MBD? Lamb EJ; Delaney MP Perit Dial Int; 2014; 34(7):687-91. PubMed ID: 25520480 [No Abstract] [Full Text] [Related]
19. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure. Coen G; Mazzaferro S; Ballanti P; Bonucci E J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330 [No Abstract] [Full Text] [Related]